The NIH Catalyze program empowers innovators to fast-track heart, lung, blood, and sleep (HLBS) discoveries toward real-world impact.
January 5, 2026
NIH
January 2, 2026
Foreign Risk vs. SBA Red Tape Hotline
This summer we posted about the unfortunate circumstances some of our NIH applicants have had with failing to pass the foreign risk assessment.
August 29, 2025
NIH Applications rejected for failing Foreign Risk Assessment
Recently we have had numerous NIH SBIR/STTR proposals rejected because they have failed the foreign risk assessment.
August 25, 2025
Safeguarding Originality: NIH’s New Limits on AI Use and Application Volume
Note: Ironically written by ChatGPT and edited by real humans.
February 10, 2025
Notice of NIH indirect rate decrease to 15%
Historically the NIH has allowed a 40% indirect rate on SBIR and STTR grants without requiring backing evidence.
October 21, 2024
NCI STEP – SBIR/STTR Training and Entrepreneurship Program
The National Cancer Institute has created a new Phase 0 program for interested US-based businesses to use.
October 1, 2024
NIH Grants vs. NIH Contracts (SBIR/STTR)
The NIH is unique amongst SBIR/STTR granting agencies in that it offers both grants and contracts.
June 13, 2024
Kindling Connections: Dr. Robert Lochhead
Robert Lochhead PhD., Assistant Professor at the Medical College of Wisconsin and Founder of Lochhead Scientific.
March 11, 2024
Helping innovators access NIH SBIR/STTR
On February 29th CTC hosted an in-depth workshop assisting 5 small businesses, some with MCW affiliation, to prepare a very important part of an NIH SBIR/STTR proposal.
October 11, 2023
Stem Pharm enters exciting collaboration with Verge Genomics
Congratulations to Stem Pharm – a CTC client, SBIR Advance awardee and Wisconsin Innovation Award winner – on their recently announced collaboration to develop a disease model to validate novel targets identified by Verge Genomics for Parkinson’s disease (PD).